REPL Replimune Group, Inc. BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

Replimune Group (REPL) Stock: Buy, Sell, or Hold?

$23.28
+1.02 (+4.58%) β–²
5d: +12.74% 30d: +78.12% 90d: +52.76%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (16%)
Quality Score
33/100
Position
EXTENDED
30-Day Fair Range
$11.09 – $18.95
Position: EXTENDED
Forward P/E & Valuation
-11.2x
Next 12M consensus est.
Wall Street Target
$23.33
+0.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.50 / $23.41
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: REPL is 22.8% above its trading range ($18.95). While momentum could continue, risk/reward favors waiting for a pullback.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Oct 28, 2026 at $16.06 · last confirmed Nov 6, 2026

Strength: 7.6/10

Get Alerted When REPL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: REPL is currently trading at $23.28, which is considered extended relative to its 30-day fair value range of $11.09 to $18.95.

Technical Outlook: Technically, REPL is in a strong downtrend. The price is approaching resistance at $23.41. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.6% recently.

Market Sentiment: REPL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $11.09 - $18.95
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 15.8%

Trading Range & Key Levels

30-Day Trading Range $11.09 - $18.95
Current vs Trading Range EXTENDED
Support Level $12.50
Resistance Level $23.41
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Protect Your Profits

REPL is technically overbought (RSI 83). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+22.8% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.6%)
  • NEUTRAL: Near Wall St target ($23.33)
  • WARNING: Composite score 33/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -11.17
Wall Street Target $23.33 (+0.2%)
Share REPL Analysis

Share this live REPL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (REPL)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits user with 411 followers expressed a bullish outlook on $REPL, mentioning IOVA and OBX as having lower price targets. No recent news articles were available.
Key Retail Themes: Bullish outlook on $REPL
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:52 PM ET
Data refreshes hourly during market hours. Next update: 10:52 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for REPL.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 43 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 37 SELL
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 39 SELL
ARWR
Arrowhead Pharmaceutical…
STRONG BUY
15 analysts
$108 47 HOLD
MIRM
Mirum Pharmaceuticals Inc
STRONG BUY
14 analysts
$155 45 HOLD

Advanced REPL Option Strategies

Professional options setups generated by AI based on today's REPL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive REPL Research Pages
REPL Technical Chart REPL Price Prediction REPL Intrinsic Value DCF REPL Earnings Date Why is REPL Moving Today? REPL Investment Advisor REPL Fair Price Analyzer REPL Options Chain REPL Options Advisor REPL Options Analysis REPL Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals